Upenn Immune Health News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Upenn immune health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Upenn Immune Health Today - Breaking & Trending Today

Breaking News | Study suggests persons who recover from COVID-19 may need one vaccine dose


By Sola Ogundipe
Those who have had COVID-19 may only need one vaccine dose, a new study suggests People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but a little immune benefit after the second dose, according to new research from the Penn Institute of Immunology.
The findings, published in Science Immunology, suggest only a single vaccine dose may be needed to produce a sufficient antibody response.
The team found that those who did not have COVID-19 called COVID naïve did not have a full immune response until after receiving their second vaccine dose, reinforcing the importance of completing the two recommended doses for achieving strong levels of immunity. ....

South Africa , South African , Sola Ogundipe , Jeffrey Lurie , E John Wherry , Joel Embiid , David Blitzer , Josh Harris , Century Scholar Fund , University Of Pennsylvania Perelman School Medicine , Allen Institute For Immunology , Research On Coronavirus , Penn Institute Of Immunology , Department Of Systems Pharmacology , Cancer Research Institute , Chen Family Research Fund , Perelman School Of Medicine , University Of Pennsylvania Health System , Mark Foundation Fellowship , Penn Center , University Of Pennsylvania , Parker Institute For Cancer Immunotherapy , Upenn Immune Health , Penn Institute , Science Immunology , New Zone ,

Study suggests persons who recover from COVID-19 may need one vaccine dose


Study suggests persons who recover from COVID-19 may need one vaccine dose
On
By Sola Ogundipe
Those who have had COVID-19 may only need one vaccine dose, a new study suggests People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but a little immune benefit after the second dose, according to new research from the Penn Institute of Immunology.
The findings, published in Science Immunology, suggest only a single vaccine dose may be needed to produce a sufficient antibody response.
The team found that those who did not have COVID-19 called COVID naïve did not have a full immune response until after receiving their second vaccine dose, reinforcing the importance of completing the two recommended doses for achieving strong levels of immunity. ....

South Africa , South African , Sola Ogundipe , Jeffrey Lurie , E John Wherry , Joel Embiid , David Blitzer , Josh Harris , Century Scholar Fund , University Of Pennsylvania Perelman School Medicine , Allen Institute For Immunology , Research On Coronavirus , Penn Institute Of Immunology , Department Of Systems Pharmacology , Cancer Research Institute , Chen Family Research Fund , Perelman School Of Medicine , University Of Pennsylvania Health System , Mark Foundation Fellowship , Penn Center , University Of Pennsylvania , Parker Institute For Cancer Immunotherapy , Upenn Immune Health , Kindly Share This Story , Penn Institute , Science Immunology ,

Penn Study Suggests Those Who Had COVID-19 May Only Need One Vaccine Dose


Date Time
Penn Study Suggests Those Who Had COVID-19 May Only Need One Vaccine Dose
PHILADELPHIA People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune benefit after the second dose, according to new research from the Penn Institute of Immunology. The findings, published today in Science Immunology, suggest only a single vaccine dose may be needed to produce a sufficient antibody response. The team found that those who did not have COVID-19 called COVID naïve did not have a full immune response until after receiving their second vaccine dose, reinforcing the importance of completing the two recommended doses for achieving strong levels of immunity. ....

University Of Pennsylvania , United States , South Africa , South African , Jeffrey Lurie , E John Wherry , Joel Embiid , David Blitzer , Josh Harris , Century Scholar Fund , University Of Pennsylvania Perelman School Medicine , Allen Institute For Immunology , Research On Coronavirus , Penn Institute Of Immunology , Cancer Research Institute , University Of Pennsylvania Health System , Chen Family Research Fund , Perelman School Of Medicine , Mark Foundation Fellowship , Penn Center , Parker Institute For Cancer Immunotherapy , Upenn Immune Health , Penn Institute , Science Immunology , Systems Pharmacology , Translational Therapeutics ,